Navigation Links
Generex Announces $1,225,000 Capital Investment
Date:6/17/2013

an offer to buy these securities, nor shall there be any offer or sale of these securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.  The shares of convertible preferred stock, warrants, the shares of common stock underlying the convertible preferred stock and the warrants, the shares of common stock issuable in lieu of the cash payment of dividends on the convertible preferred stock payable, and the share of common stock issuable as a finder's fee in this transaction were offered privately pursuant to Regulation D under the Securities Act of 1933.  The Company has agreed with the investors to file a registration statement with the Securities and Exchange Commission covering the public resale of the common stock issuable upon conversion of the preferred stock, issuable as dividends on the preferred stock and issued upon and exercise of the warrants.  The Company has agreed to file the registration statement within 25 days after closing and to use its best efforts to have the registration statement declared effective within 75 days after closing.  

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Expre
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ASCO Interview of MD Andersons Mittendorf on AE37 Breast Cancer Vaccine Now Available on Generex Websites
2. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
3. Generex Announces ASCO Presentations of AE37 Vaccine Data; Potential Leading Immunotherapy Option for Breast Cancer Patients
4. Positive Generex Data Underscores Cancer Immunotherapy Forecast Issued by Citi
5. Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
6. Generex Touts Pipeline Potential of Antigen Express Subsidiary
7. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
8. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
9. Generex Announces Details of Investor Conference Call
10. Generex Addresses Recent Trading Volume in Shares of its Common Stock
11. Generex Announces Results of Annual Stockholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... -- Larry J. Merlo , President and CEO of ... the National Press Club in Washington, D.C. ... stop selling tobacco products and its leadership in driving the ... "Dramatic changes in our health care system pose enormous challenges ... said. "CVS Health has a truly unique combination of business ...
(Date:9/19/2014)... -- Alere Inc. (NYSE: ALR ), a global ... in support of President Barack Obama,s Executive ... leader in rapid diagnostics for infectious disease, we commend ... the serious threat of antibiotic resistance. We look forward ... to promote the development of rapid point-of-care tests that, ...
(Date:9/19/2014)... 19, 2014  Lpath, Inc. (NASDAQ: ... therapeutics, announced today that it has entered into ... common stock and 3,605,042 unregistered warrants in a ... one registered share of common stock and one ... common stock will be $3.475.  The warrants have ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
(Date:9/19/2014)... Capital Region Periodontics and Dental ... to announce the latest addition to their treatment ... those needing dental implants. Often referred to as ... the fear factor normally associated with traditional gum ... bleeding make, this procedure a very attractive oral ...
(Date:9/19/2014)... from the wonder material graphene has been used to ... cancer. , The biosensor has been shown to ... tests currently in use, and was able to provide ... possibility of a rapid, point-of-care diagnostic tool for patients. ... in IOP Publishing,s journal 2D Materials . , ...
(Date:9/19/2014)... 19, 2014 The ... Scandinavian style of eating, is making its ... Diet Doc’s medical weight loss ... eating good food which leads to improved ... teaching patients to understand how diet can ...
(Date:9/19/2014)... UT (PRWEB) September 19, 2014 Activz ... Activz Greens Smoothie product, a new whole-food produce ... in Baltimore, MD. Activz Greens Smoothie ... combined in one convenient – and absolutely delicious —Greens ... 18th-20th in Baltimore, MD. , The ...
(Date:9/19/2014)... Centre for Accident Research & Road Safety - Queensland ... in Transport Conference (OSIT) which is being held on ... Blackman, a CARRS-Q road safety researcher, said speed limit ... limits and related traffic controls remained in place at ... If people are asked to slow down at roadwork ...
Breaking Medicine News(10 mins):Health News:Albany, NY Periodontist Reed Ference, DMD, Calms Fears of Patients with Gum Disease by Offering LANAP®, An Advanced, Less Invasive Treatment Solution 2Health News:Albany, NY Periodontist Reed Ference, DMD, Calms Fears of Patients with Gum Disease by Offering LANAP®, An Advanced, Less Invasive Treatment Solution 3Health News:Graphene sensor tracks down cancer biomarkers 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 3Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 4Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 2Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 3Health News:Don't cry wolf: Drivers fed up with slowing down at inactive roadwork sites 2
... study called 'HERS' conducted by researchers of the University of ... found that Hormone Replacement Therapy (HRT) may be able to ... to develop diabetes as well. ,The study involved some ... or had "impaired fasting glucose" - a condition with ...
... is bad for health is almost an established truth now. ... damage a single serving of pizza could do to our ... group, called the Centre //for Science in the Public Interest ... 15 varieties of pizzas and looked at dietary information provided ...
... recent study by researchers in the Institute of Preventive ... be beneficial in countering dementia and Alzheimer's disease. Scientists, ... monthly were more than two times less likely to ... there may be substances in wine which reduce the ...
... the key to survival on planet earth. Every one of ... happy living. But how many of us know that the ... pressure, continuously over a 24 hour period? According to a ... strained, there may be long-term effects on heart health. ...
... A supplemental new drug application (sNDA) for Valtrex (valacyclovir ... and Drug Administration (FDA) for the treatment of cold ... which also added that this new application for Valtrex// ... to shorten the duration of a cold sore outbreak. ...
... larger portions lead to greater energy intake, meaning, larger the ... Researchers also studied whether the response to portion size differed ... plate. ,The study was carried out with 50 men ... for four weeks. While one group was given a specific ...
Cached Medicine News:Health News:Pizza is bad for health. But, do you know how bad? 2Health News:Unhappy relationships could result in more than just heart breaks! 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: